TUSTIN, CA--(Marketwire - September 15, 2010) - Avid Bioservices, Inc., a leading provider of integrated commercial and clinical manufacturing services and a subsidiary of Peregrine Pharmaceuticals, Inc., today announced that company representatives would host exhibits at two upcoming conferences to share Avid's experience helping clients accelerate drug development process and time to market.

"We are excited to share with potential clients our truly unique capabilities, which exceed the services of typical CMOs," said Chris Eso, vice president of business operations. "Our focus on quality biomanufacturing spans the complete process chain, from cell line development to process development to analytical methods development through to manufacturing and fill/finish services. These capabilities, combined with our parent company's biologics regulatory expertise, help our clients navigate and accelerate a biologic drug to market."

Conference details:

Bioprocess International conference and exhibition, Providence RI, September 20-24, 2010
Accelerating and Optimizing Biopharmaceutical Process and Product Development
Avid will host an exhibit at booth #709
For additional information on this conference please visit: http://www.ibclifesciences.com/bpi/overview.xml

9th Annual Contract Pharma 2010 Contracting & Outsourcing Conference 
Hyatt Regency, New Brunswick, NJ, Thursday, September 23, 2010
Avid will share materials at table #109
For additional information on this conference please visit: http://www.contractpharma.com/2010conference

About Avid Bioservices
Avid Bioservices provides a comprehensive range of high quality cGMP manufacturing services for the biotechnology and biopharmaceutical industries to support manufacturing of cGMP commercial and clinical products. With over 10 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cell banking, stability testing, clinical and commercial product manufacturing and purification, bulk packaging, final product filling and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line optimization, analytical methods development and product characterization. For more information about Avid, please visit www.avidbio.com.

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc., which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Contact Information:

Amy Figueroa
Peregrine Pharmaceuticals
(800) 987-8256